StreetInsider.com News Articles

Longeveron sets 1-for-10 reverse stock split effective Aug. 26

Mon, 24 Aug 2026 16:05:17 -0400

Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company, announced a 1-for-10 reverse stock split of its Class A and Class B common stock, effective at 11:59 p.m. Eastern Time on Aug. 26, 2026. The stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at the opening of trading on Aug. 27, 2026, under the existing ticker symbol "LGVN" and a new CUSIP number 54303L 302.

The reverse split was approved by stockholders at the company's annual meeting on July 1, 2026, and by the board of directors on July 31, 2026. The company stated the

Longeveron sets 1-for-10 reverse stock split effective Aug. 26

Mon, 24 Aug 2026 16:05:17 -0400

The reverse split was approved by stockholders at the company's annual meeting on July 1, 2026, and by the board of directors on July 31, 2026. The company stated the

Longeveron sets 1-for-10 reverse stock split effective Aug. 26

Mon, 24 Aug 2026 16:05:17 -0400

The reverse split was approved by stockholders at the company's annual meeting on July 1, 2026, and by the board of directors on July 31, 2026. The company stated the

Longeveron sets 1-for-10 reverse stock split effective Aug. 26

Mon, 24 Aug 2026 16:05:17 -0400

The reverse split was approved by stockholders at the company's annual meeting on July 1, 2026, and by the board of directors on July 31, 2026. The company stated the

Longeveron sets 1-for-10 reverse stock split effective Aug. 26

Mon, 24 Aug 2026 16:05:17 -0400

The reverse split was approved by stockholders at the company's annual meeting on July 1, 2026, and by the board of directors on July 31, 2026. The company stated the

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

MIAMI, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company will undertake a 1-for-10 reverse split of the Company’s Class A common stock, par value $0.001 per share and Class B common stock, par value $0.001 per share (collectively, the “Common Stock”) (the “2026 Reverse Split”). The 2026 Reverse Split was previously approved by the Company’s stockholders at the Company’s annual meeting held on July 1, 2026 and the Company’s Board

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron Announces 1-for-10 Reverse Stock Split

Mon, 24 Aug 2026 16:05:00 -0400

Longeveron names Nirav Jhaveri as CFO

Wed, 19 Aug 2026 16:05:16 -0400

Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.